» Articles » PMID: 16721556

P(2) Purinoceptors Account for the Non-nitrergic NANC Relaxation in the Rat Ileum

Overview
Specialty Pharmacology
Date 2006 May 25
PMID 16721556
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The transmitters involved in the non-nitrergic component of the non-adrenergic, non-cholinergic (NANC) inhibitory response of the rat small intestinal longitudinal muscle to electrical field stimulation of its nerves is a matter of controversy. The present study is the first one to utilise a combination of a nitric oxide synthase inhibitor and a P(2) purinoceptor antagonist for studying this response. We found that the P(2) purinoceptor antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS; 5x10(-5) M) abolished the non-nitrergic NANC relaxation to electrical field stimulation (10 Hz). PPADS alone provided a significant, moderate inhibitory action. PPADS specifically inhibited relaxations due to exogenous adenosine 5'-triphosphate (ATP) or alpha,beta-methylene ATP. The guanylate cyclase blocker 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 10(-6) M) did not add to the inhibitory action of N(G)-nitro-L-arginine on field stimulation-induced relaxation. ODQ abolished the relaxant effect of the nitric oxide donors nitroglycerin or sodium nitroprusside. These data indicate that: (1) nitric oxide and ATP fully account for the field stimulation-induced relaxation in the rat ileal strip under the experimental conditions of this study, and (2) no ODQ-sensitive guanylate cyclase-mediated mechanism is involved in the non-nitrergic component of the NANC relaxation.

Citing Articles

P2Y receptor-mediated transient relaxation of rat longitudinal ileum preparations involves phospholipase C activation, intracellular Ca(2+) release and SK channel activation.

Mader F, Krause L, Tokay T, Hakenberg O, Kohling R, Kirschstein T Acta Pharmacol Sin. 2016; 37(5):617-28.

PMID: 27018177 PMC: 4857539. DOI: 10.1038/aps.2015.137.


Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Burnstock G Purinergic Signal. 2013; 10(1):3-50.

PMID: 24307520 PMC: 3944042. DOI: 10.1007/s11302-013-9397-9.


Purinergic mechanisms in the control of gastrointestinal motility.

Bornstein J Purinergic Signal. 2008; 4(3):197-212.

PMID: 18368521 PMC: 2486340. DOI: 10.1007/s11302-007-9081-z.

References
1.
Tanovic A, Jimenez M, Fernandez E . Actions of NO donors and endogenous nitrergic transmitter on the longitudinal muscle of rat ileum in vitro: mechanisms involved. Life Sci. 2001; 69(10):1143-54. DOI: 10.1016/s0024-3205(01)01198-5. View

2.
Belai A, Burnstock G . Evidence for coexistence of ATP and nitric oxide in non-adrenergic, non-cholinergic (NANC) inhibitory neurones in the rat ileum, colon and anococcygeus muscle. Cell Tissue Res. 1994; 278(1):197-200. DOI: 10.1007/BF00305792. View

3.
Ziganshin A, Ziganshina L, King B, Pintor J, Burnstock G . Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus laevis. Biochem Pharmacol. 1996; 51(7):897-901. DOI: 10.1016/0006-2952(95)02252-x. View

4.
Ekblad E, Sundler F . Motor responses in rat ileum evoked by nitric oxide donors vs. field stimulation: modulation by pituitary adenylate cyclase-activating peptide, forskolin and guanylate cyclase inhibitors. J Pharmacol Exp Ther. 1997; 283(1):23-8. View

5.
Allescher H, Sattler D, Piller C, Schusdziarra V, Classen M . Ascending neural pathways in the rat ileum in vitro--effect of capsaicin and involvement of nitric oxide. Eur J Pharmacol. 1992; 217(2-3):153-62. DOI: 10.1016/0014-2999(92)90839-v. View